These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7404343)

  • 1. [General aspects of management and immunosuppressive therapy of chronic active hepatitis].
    Tareev EM; Aprosina ZG
    Ter Arkh; 1980; 52(4):7-13. PubMed ID: 7404343
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current aspects of the therapy of chronic hepatitis (a review of the literature)].
    Cherednichenko TV
    Vopr Okhr Materin Det; 1979 Nov; 24(11):43-8. PubMed ID: 388858
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunosuppressive therapy in active chronic hepatopathies].
    Buligescu L; Ciontea M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1978; 30(3):241-56. PubMed ID: 30138
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic hepatitis--various aspects of the problem].
    Ryss EA; Fishzon-Ryss IuI
    Klin Med (Mosk); 1991 Sep; 69(9):6-11. PubMed ID: 1803154
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of therapy using combination of immunosuppressive agents in active chronic hepatitis--report of 2 cases and a review of the literature].
    Okada M; Maruyama T; Yutani C; Morita K; Yoshimi H
    Nihon Rinsho; 1972 Mar; 30(3):853-9. PubMed ID: 5064554
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical treatment of chronic hepatitis. Results of a retrospective study.
    Thaler H
    Tokai J Exp Clin Med; 1980 Jul; 5(3):361-6. PubMed ID: 7222126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoimmune hepatitis].
    Manns MP; Strassburg CP
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():39-42. PubMed ID: 12467006
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic aggressive hepatitis B: effectiveness of the control of immunosuppressive therapy. Value of biopsy and laboratory chemical procedures].
    Ohlen J; Selmair H
    Fortschr Med; 1986 Apr; 104(16):323-5. PubMed ID: 3710399
    [No Abstract]   [Full Text] [Related]  

  • 9. [What can be said against the management of HBsAg-positive chronic hepatitis using steroids or immunosuppressive agents?].
    Strohmeyer G; Thier W
    Internist (Berl); 1979 Apr; 20(4):188-92. PubMed ID: 374303
    [No Abstract]   [Full Text] [Related]  

  • 10. [Should chronic active viral hepatitis be treated with drugs or not?].
    Schalm SW
    Internist (Berl); 1981 Dec; 22(12):717-20. PubMed ID: 7033161
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of periarteritis nodosa with immunosuppressants].
    Semenkova EN; Lopatkina TN
    Ter Arkh; 1985; 57(8):17-20. PubMed ID: 2866597
    [No Abstract]   [Full Text] [Related]  

  • 12. [Etiopathogenetic aspects and immunosuppressive treatment of active chronic hepatitis].
    Miglio F; Facchini A; Stefanini GF; Mariani E; Gasbarrini GB; Labò G
    Recenti Prog Med; 1977 Apr; 62(4):471-88. PubMed ID: 577618
    [No Abstract]   [Full Text] [Related]  

  • 13. Disappearance of hepatitis B surface antigen in chronic type B hepatitis after clinical and laboratorial relapse produced by abrupt withdrawal of immunosuppressive drugs.
    da Silva LC; Mattar E; Carrilho FJ; Takeda A; Sette Júnior H; Gayotto LC
    Rev Inst Med Trop Sao Paulo; 1983; 25(6):270-4. PubMed ID: 6608779
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current therapeutic management of chronic hepatitis].
    Oancea R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982; 34(4):289-302. PubMed ID: 6131511
    [No Abstract]   [Full Text] [Related]  

  • 15. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic principles after liver transplantation].
    Lengyel G
    Orv Hetil; 1996 Oct; 137(42 Suppl 1):2379-81. PubMed ID: 9045122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of difficult-to-treat autoimmune hepatitis successfully managed by TNF-alpha blockade.
    Weiler-Normann C; Wiegard C; Schramm C; Lohse AW
    Am J Gastroenterol; 2009 Nov; 104(11):2877-8. PubMed ID: 19888264
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis.
    Valsakumar AK; Valappil UC; Jorapur V; Garg N; Nityanand S; Sinha N
    J Rheumatol; 2003 Aug; 30(8):1793-8. PubMed ID: 12913937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Active hepatitis B vaccination in ulcerative colitis treated with azathioprine].
    Hinrichsen H; Fölsch UR
    Internist (Berl); 1999 Mar; 40(3):327-8. PubMed ID: 10205763
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of the Adamantiades-Behçet syndrome using an immunosuppressive agent (azathioprine) and prednisolone].
    Psilas K; Sideroglou P
    Bull Mem Soc Fr Ophtalmol; 1983; 95():417-22. PubMed ID: 6677350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.